|
Market Closed -
OTC Markets
20:31:28 04/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0290 USD | +6.62% |
|
+107.14% | -52.77% |
| 08-14 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-14 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.25M 2.86M 2.7M 2.46M 4.6M 312M 4.64M 32.36M 12.54M 159M 12.21M 11.94M 517M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.97M 4.37M 4.12M 3.76M 7.03M 477M 7.09M 49.45M 19.16M 243M 18.66M 18.26M 790M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +6.62% | ||
| 1 week | +107.14% | ||
| Current month | +55.08% | ||
| 1 month | +55.91% | ||
| 3 months | +31.82% | ||
| 6 months | -21.41% | ||
| Current year | -52.77% |
| 1 week | 0.01 |  | 0.03 |
| 1 month | 0.01 | | 0.03 |
| Current year | 0.01 | | 0.1 |
| 1 year | 0.01 | | 0.1 |
| 3 years | 0.01 | | 0.1 |
| 5 years | 0.01 | | 0.27 |
| 10 years | 0.01 | | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 18/02/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.62% | +107.14% | -14.71% | -36.78% | 2.94M | |
| +2.68% | +2.56% | +59.32% | +114.68% | 1,026B | |
| +0.56% | +0.17% | +53.19% | +68.65% | 649B | |
| +0.02% | +0.42% | +20.51% | +73.58% | 468B | |
| +0.06% | +0.61% | +39.82% | +45.71% | 352B | |
| +1.16% | +2.53% | +21.60% | +29.39% | 271B | |
| -0.24% | -0.23% | +10.62% | +12.26% | 256B | |
| -0.01% | +6.91% | +45.42% | +51.68% | 220B | |
| -1.11% | -0.80% | +31.69% | +99.56% | 188B | |
| +0.30% | -9.43% | -31.91% | -60.56% | 170B | |
| Average | +0.73% | +0.47% | +23.56% | +39.82% | 359.91B | |
| Weighted average by Cap. | +0.12% | +1.06% | +38.36% | +67.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.81M 13.02M 11.88M 22.22M 1.51B 22.39M 156M 60.56M 767M 58.97M 57.69M 2.5B | 13.79M 12.13M 11.43M 10.43M 19.51M 1.32B 19.66M 137M 53.17M 674M 51.77M 50.65M 2.19B |
| Net income | -2.39M -2.11M -1.99M -1.81M -3.39M -230M -3.41M -23.82M -9.23M -117M -8.99M -8.79M -381M | -958K -843K -794K -725K -1.36M -91.96M -1.37M -9.53M -3.69M -46.8M -3.6M -3.52M -152M |
| Net Debt | 325K 286K 269K 246K 460K 31.2M 463K 3.23M 1.25M 15.88M 1.22M 1.19M 51.67M | 1.72M 1.51M 1.42M 1.3M 2.43M 165M 2.45M 17.09M 6.62M 83.93M 6.45M 6.31M 273M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | $0.0144 | +10.77% | 1,233,798 |
| 23/09/26 | $0.0130 | -13.33% | 1,107,468 |
| 22/09/26 | $0.0150 | +7.14% | 202,195 |
| 21/09/26 | $0.0140 | -.--% | 675,174 |
| 18/09/26 | $0.0140 | -.--% | 1,741,848 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
